Ana L Silva

1.2k total citations
11 papers, 937 citations indexed

About

Ana L Silva is a scholar working on Immunology, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Ana L Silva has authored 11 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Molecular Biology and 3 papers in Pharmaceutical Science. Recurrent topics in Ana L Silva's work include Immunotherapy and Immune Responses (8 papers), RNA Interference and Gene Delivery (4 papers) and vaccines and immunoinformatics approaches (3 papers). Ana L Silva is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), RNA Interference and Gene Delivery (4 papers) and vaccines and immunoinformatics approaches (3 papers). Ana L Silva collaborates with scholars based in Netherlands, Switzerland and United Kingdom. Ana L Silva's co-authors include Ferry Ossendorp, Wim Jiskoot, Rodney Alexander Rosalia, Jaap Oostendorp, Peter C. Soema, Bram Slütter, Sjoerd H. van der Burg, Eleni Maria Varypataki, Luis J. Cruz and Angelino T. Tromp and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ana L Silva

11 papers receiving 923 citations

Peers

Countries citing papers authored by Ana L Silva

Since Specialization

Citations

This map shows the geographic impact of Ana L Silva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana L Silva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana L Silva more than expected).

Fields of papers citing papers by Ana L Silva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana L Silva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana L Silva. The network helps show where Ana L Silva may publish in the future.

Co-authorship network of co-authors of Ana L Silva

This figure shows the co-authorship network connecting the top 25 collaborators of Ana L Silva. A scholar is included among the top collaborators of Ana L Silva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana L Silva. Ana L Silva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Characterization of AreABC, an RND-Type Efflux System Involved in Antimicrobial Resistance of Aliarcobacter butzleri 2021 ·Antimicrobial Agents and Chemotherapy ·Susana Ferreira, Ana L Silva, Joana Tomás, (unknown), Fernanda Domingues, Mónica Oleastro	9
2	Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles 2016 ·Journal of Controlled Release ·Eleni Maria Varypataki, Ana L Silva, Christophe Barnier-Quer, Nicolas Collin, Ferry Ossendorp, Wim Jiskoot	79
3	PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity 2016 ·Human Vaccines & Immunotherapeutics ·Ana L Silva, Peter C. Soema, Bram Slütter, Ferry Ossendorp, Wim Jiskoot	194
4	Poly-(lactic-co-glycolic-acid)-based particulate vaccines: Particle uptake by dendritic cells is a key parameter for immune activation 2015 ·Vaccine ·Ana L Silva, Rodney Alexander Rosalia, Eleni Maria Varypataki, (unknown), Ferry Ossendorp, Wim Jiskoot	108
5	CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses 2014 ·Biomaterials ·Rodney Alexander Rosalia, Luis J. Cruz, Suzanne van Duikeren, Angelino T. Tromp, Ana L Silva, Wim Jiskoot, Tanja D. de Gruijl, Clemens W.G.M. Löwik, Jaap Oostendorp, Sjoerd H. van der Burg, Ferry Ossendorp	225
6	PLGA nanoparticles enhance the expression of retinaldehyde dehydrogenase enzymes in dendritic cells and induce FoxP3+ T-cells in vitro 2013 ·Journal of Controlled Release ·Chantal Keijzer, Rachel Spiering, Ana L Silva, Willem van Eden, Wim Jiskoot, Lonneke Vervelde, Femke Broere	24
7	Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles 2013 ·Cancer Immunology Immunotherapy ·Rodney Alexander Rosalia, Ana L Silva, Marcel Camps, Ahmed A. Allam, Wim Jiskoot, Sjoerd H. van der Burg, Ferry Ossendorp, Jaap Oostendorp	21
8	Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T‐cell activation 2013 ·European Journal of Immunology ·Rodney Alexander Rosalia, Esther D. Quakkelaar, Anke Redeker, Selina Khan, Marcel Camps, Jan W. Drijfhout, Ana L Silva, Wim Jiskoot, Thorbald van Hall, Peter A. van Veelen, George M. C. Janssen, Kees L. M. C. Franken, Luis J. Cruz, Angelino T. Tromp, Jaap Oostendorp, Sjoerd H. van der Burg, Ferry Ossendorp, Cornelis J.M. Melief	153
9	Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: Low-burst release is crucial for efficient CD8+ T cell activation 2012 ·European Journal of Pharmaceutics and Biopharmaceutics ·Ana L Silva, Rodney Alexander Rosalia, (unknown), Myrra G. Carstens, Ferry Ossendorp, Jaap Oostendorp, Wim Jiskoot	88
10	Immune Responses during Human Schistosomiasis Mansoni 1986 ·Scandinavian Journal of Immunology ·Alexandra A. Garciá, Ana L Silva, (unknown), Naftale Katz, G. Gazzinelli, Daniel G. Colley	9
11	Immune Responses during Human Schistosomiasis Mansoni 1983 ·Scandinavian Journal of Immunology ·Daniel G. Colley, Naftale Katz, R. S. Rocha, (unknown), Ana L Silva, G. Gazzinelli	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact